{"database":"GEO","file_versions":[{"headers":{"Content-Type":["application/json"]},"body":{"files":{"Other":["ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE188nnn/GSE188470/"]},"type":"primary"},"statusCode":"OK","statusCodeValue":200}],"scores":null,"additional":{"omics_type":["Genomics"],"species":["Homo sapiens"],"gds_type":["Genome binding/occupancy profiling by high throughput sequencing"," Expression profiling by high throughput sequencing"],"full_dataset_link":["https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE188470"],"repository":["GEO"],"entry_type":["GSE"],"additional_accession":[]},"is_claimable":false,"name":"Human dermal fibroblasts (HDF), BRAF-V600E positive (MaMel21 and MaMel63a), and BRAF-WT malignant melanoma cell lines (SBcl2 and WM3438) after vemurafenib or DMSO treatment","description":"This SuperSeries is composed of the SubSeries listed below.","dates":{"publication":"2021/12/11"},"accession":"GSE188470","cross_references":{"GSM":["GSM5322221","GSM5322222","GSM5322220","GSM5322225","GSM5322226","GSM5322223","GSM5322224","GSM5322229","GSM5322227","GSM5683480","GSM5322228","GSM6658657","GSM5683486","GSM5683485","GSM6658658","GSM5683488","GSM6658659","GSM5683487","GSM5683482","GSM5683481","GSM5683484","GSM5683483","GSM5683489","GSM6658660","GSM5683491","GSM5683490","GSM5683497","GSM5683496","GSM5683499","GSM5683498","GSM5683493","GSM5683492","GSM5683495","GSM5683494","GSM5683457","GSM5683456","GSM5683459","GSM5683458","GSM5683464","GSM5683463","GSM5683466","GSM5683465","GSM5683460","GSM5683462","GSM5683461","GSM5683468","GSM5683501","GSM5683467","GSM5683500","GSM5683503","GSM5683502","GSM5683469","GSM5322218","GSM5322219","GSM5683475","GSM5683474","GSM5683477","GSM5683476","GSM5683471","GSM5683470","GSM5683473","GSM5683472","GSM5683479","GSM5683478"],"GPL":["20301","24676"],"GSE":["188470"],"taxon":["Homo sapiens"],"PMID":["[34930313]"]}}